IGF2BP1 and neuroblastoma: ,204 Thus, IGF2BP1 has attracted attention for its potential to serve as a biomarker for diagnosis and prognosis for abovementioned cancers, as well as for other cancers including uveal melanoma, breast cancer, neuroblastoma, esophageal cancer, and cervical cancer.49